BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study (*) is to evaluate the progression free survival rate at 6 months,
response rate, overall disease control rate, overall survival of BAY-43-9006 in soft tissue
sarcoma patients.
(*) as per Protocol Amendment No. 1 of 16 April 2007 approved by local IEC on 24 July 2007